I

Initiator Pharma A/S
STO:INIT

Watchlist Manager
Initiator Pharma A/S
STO:INIT
Watchlist
Price: 7.1 SEK 2.9% Market Closed
Market Cap: 375.7m SEK
Have any thoughts about
Initiator Pharma A/S?
Write Note

Initiator Pharma A/S
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Initiator Pharma A/S
Total Equity Peer Comparison

Comparables:
GMAB
ZEAL
ASND
B
BAVA
BIOPOR

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
I
Initiator Pharma A/S
STO:INIT
Total Equity
kr11.2m
CAGR 3-Years
-8%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Genmab A/S
CSE:GMAB
Total Equity
kr31B
CAGR 3-Years
15%
CAGR 5-Years
30%
CAGR 10-Years
33%
Zealand Pharma A/S
CSE:ZEAL
Total Equity
kr8.9B
CAGR 3-Years
96%
CAGR 5-Years
45%
CAGR 10-Years
40%
Ascendis Pharma A/S
NASDAQ:ASND
Total Equity
-€321.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Bavarian Nordic A/S
CSE:BAVA
Total Equity
kr10.4B
CAGR 3-Years
22%
CAGR 5-Years
39%
CAGR 10-Years
27%
Bioporto A/S
CSE:BIOPOR
Total Equity
kr104.8m
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
12%

See Also

What is Initiator Pharma A/S's Total Equity?
Total Equity
11.2m DKK

Based on the financial report for Dec 31, 2023, Initiator Pharma A/S's Total Equity amounts to 11.2m DKK.

What is Initiator Pharma A/S's Total Equity growth rate?
Total Equity CAGR 5Y
-8%

Over the last year, the Total Equity growth was -67%. The average annual Total Equity growth rates for Initiator Pharma A/S have been -8% over the past three years , -8% over the past five years .

Back to Top